Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Factors Predicting Efficacy and Toxicity of Post Transplantation Cyclophosphamide for Graft Versus Host Disease Prevention in Hematopoietic Cell Transplantation Recipients: Interim Data of an Ongoing Study

Aleksander L. Chojecki, Jai N. Patel, David M Foureau, James Symanowski, Xhevahire Begic, Michael Davis, Nury M Steuerwald, Sarah Norek, Srinivasa Reddy R. Sanikommu, Nilay A. Shah, Brittany Knick Ragon, Thomas G. Knight, Jing Ai, Michael R. Grunwald, Nilanjan Ghosh, Lawrence J Druhan, Belinda R. Avalos, Edward A. Copelan

Blood (2022) 140 (Supplement 1): 10534–10536.

https://doi.org/10.1182/blood-2022-160214

Published: 2022

Journal Articles

Clonal Hematopoiesis Prevalence and Mutational Spectrum in Patients with Plasma Cell Disorders at the Time of Diagnosis and Its Impact on Clinical Features, Cardiovascular Complications, and Survival

Srinivasa Reddy Sanikommu, Shebli Atrash, Myra Robinson, Nury M. Steuerwald, Kristen Cassetta, Hsih-Te Yang, Saad Usmani, Edward A. Copelan, Belinda R. Avalos, Lawrence J. Druhan

Blood (2022) 140 (Supplement 1): 11416–11417.

https://doi.org/10.1182/blood-2022-170887

Published: 2022

Journal Articles

Impact of Race, Ethnicity, and Social Determinants of Heath on Outcomes for Acute Myeloid Leukemia Patients in a System with Specialized Nurse Navigation

Brittany Knick Ragon, Danielle Boselli, Rupali Bose, Stephanie Begley, Melissa Aguiar, Kris Blackley, Nilay A. Shah, Aleksander L. Chojecki, Srinivasa Reddy R. Sanikommu, Jing Ai, Lawrence J Druhan, Nury M Steuerwald, Jai N Patel, James T. Symanowski, Belinda R. Avalos, Edward A. Copelan, Derek Raghavan, Thomas G. Knight, Michael R. Grunwald

Blood (2022) 140 (Supplement 1): 10993–10995.

https://doi.org/10.1182/blood-2022-159179

Published: 2022

Journal Articles

Heterodimerization of CSF3R Splice Variants and Mutants Alter Receptor Function

Sara L. Seegers, Amanda Lance, Steven I. Park, Belinda R. Avalos, Lawrence J Druhan

Blood (2022) 140 (Supplement 1): 5465–5466.

https://doi.org/10.1182/blood-2022-170480

Published: 2022

Journal Articles

Clinical Characteristics and Outcomes of AML Patients Treated with Frontline CPX 351 or HMA/Venetoclax: A Single Institution's Experience

Aleksander L. Chojecki, Justin Arnall, Danielle Boselli, Kristyn Y. DiSogra, Allison Karabinos, Tommy Chen, Jing Ai, Thomas G. Knight, Brittany Knick Ragon, Nilay A. Shah, Srinivasa R. Sanikommu, James T Symanowski, Belinda R Avalos, Edward A. Copelan, Michael R. Grunwald

Blood (2021) 138 (Supplement 1): 1252.

https://doi.org/10.1182/blood-2021-149811

Published: 2021

Journal Articles

Platform Incorporating Patient Navigation, Preparative Guidelines, and Hospital at Home May Improve COVID-19 Outcomes for Patients with Myeloid Malignancies

Blood (2021) 138 (Supplement 1): 3019.

https://doi.org/10.1182/blood-2021-150610

Published: 2021

Journal Articles

CSF3R Splicing Regulates Granulopoiesis Via Splice Variant Specific Responses to G-CSF

Amanda Lance, Rajeswaran Mani, Sara L. Seegers, Belinda R Avalos, Lawrence J Druhan

Blood (2021) 138 (Supplement 1): 3130.

https://doi.org/10.1182/blood-2021-154322

Published: 2021

Journal Articles

Characteristics Affecting Durability and Tolerability of Imatinib in Patients Switched from Brand to Generic and Newly Diagnosed Patients Initially Prescribed Generic Imatinib for Chronic Myeloid Leukemia

Ariel Denson, PharmD, Kristyn Y. DiSogra, PharmD, BCOP, Justin Arnall, PharmD, BCOP, Srinivasa R. Sanikommu, MD, Nilay A. Shah, MD, Brittany K. Ragon, MD, Thomas G. Knight, MD, Jing Ai, MDPhD, Michael R. Grunwald, MD, Belinda R Avalos, MD, Edward A Copelan, Aleksander L. Chojecki, MD

Blood (2020) 136 (Supplement 1): 14–17.

https://doi.org/10.1182/blood-2020-137250

Published: 2020

Journal Articles

Impact of Letermovir Prophylaxis on Voriconazole Exposure in Allogeneic Hematopoietic Cell Transplant Recipients

Issam S. Hamadeh, PharmD, Michael R. Grunwald, MD, Allison Martin, PharmD, Jai N. Patel, PharmD, Alexandra Shillingburg, PharmD, Ekaterina Kachur, PharmD, Allene COOK, PharmD, Allison Karabinos, PharmD, Jing Ai, MDPhD, Thomas G. Knight, MD, Brittany K. Ragon, MD, Aleksander L. Chojecki, MD, Nilay A. Shah, MD, Srinivasa R. Sanikommu, MD, Belinda R Avalos, MD, Edward A Copelan, Zainab Shahid, MD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-141124

Published: 2020

Journal Articles

Complex CSF3R Protein Isoform Interactions Dictate Cytokine Responsiveness

Sara L. Seegers, M.S., Amanda Lance, MS, Lawrence J Druhan, PhD, Belinda R Avalos, MD

Blood (2020) 136 (Supplement 1): 35.

https://doi.org/10.1182/blood-2020-143107

Published: 2020

Journal Articles

Specialty Pharmacy and Physician Partnership Optimizes Clinical Pathway Adherence in Myelofibrosis (MF): Initial Analysis of a Quality Improvement Initiative

Aleksander L. Chojecki, MD, Kristyn Y. DiSogra, PharmD, BCOP, Justin Arnall, PharmD, BCOP, Nicole Cowgill, PharmD, CSP, Srinivasa Reddy Sanikommu, MD, Nilay A. Shah, MD, Charles H. Packman, MD, Brittany K. Ragon, MD, Thomas G. Knight, MD, Jing Ai, MDPhD, Belinda R Avalos, MD, Edward A Copelan, Michael R. Grunwald, MD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-136319

Published: 2020

Journal Articles

Minorities Do Not Have Worse Outcomes for Diffuse Large B Cell Lymphoma (DLBCL) If Optimally Managed

Bei Hu, MD, Tommy Chen, Danielle Boselli, MS, Rupali Bose, MS, MBA, James T. Symanowski, PhD, Derek Raghavan, MDPhDFACP,FRACP, Amy Soni, MD, Steven I Park, MD, Belinda R Avalos, MD, Edward A Copelan, Ryan Jacobs, MD, Nilanjan Ghosh, MD PhD

Blood (2019) 134 (Supplement_1): 425.

https://doi.org/10.1182/blood-2019-123998

Published: 2019

Journal Articles

Patient Reported Financial Toxicity in Myeloproliferative Neoplasms

Thomas G. Knight, MD, Myra Robinson, MS, Jing Ai, MD PhD, Brittany K Ragon, MD, Rhonda Davis, RN, BSN, Cindy Shiflett, LPN, Erica Ruston, RN, BSN, Hailey Glover, RN, BSN, Jigar Trivedi, MSc, PharmD, Belinda R Avalos, MD, Jonathan M. Gerber, MD, James T Symanowski, PhD, Edward A Copelan, Michael R. Grunwald, MD

Blood (2019) 134 (Supplement_1): 2099.

https://doi.org/10.1182/blood-2019-128858

Published: 2019

Journal Articles

Alternative Splicing and Intronic Polyadenylation Post-Transcriptionally Regulate CSF3R Via a Cryptic Exon

Lawrence J Druhan, PhD, Amanda Lance, MS, Alicia Hamilton, Nury M Steuerwald, PhD, Elise Tjaden, Belinda R Avalos, MD

Blood (2019) 134 (Supplement_1): 2462.

https://doi.org/10.1182/blood-2019-129102

Published: 2019

Journal Articles

New Germline Syndrome Discovery: Heterozygous CSF3R Mutations May Predispose to Myeloid and Lymphoid Malignancies

Amy M Trottier, MDBSc,MSc, Ira L Kraft, MD, Lawrence J Druhan, PhD, Amanda Lance, MS, Belinda R Avalos, MD, Lucy A Godley, MD PhD

Blood (2019) 134 (Supplement_1): 2543.

https://doi.org/10.1182/blood-2019-129492

Published: 2019

Journal Articles

Peripheral Immune Profile and Minimal Residual Disease (MRD) Burden Following Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM)

David Foureau, PhD, Qing Zhang, PhD, Tammy D Cogdill, NP, Adina S Wynn, Nury M. Steuerwald, PhD, Lawrence J. Druhan, PhD, Fei Guo, Katherine Rigby, Kyle L Madden, BS, James T Symanowski, PhD, Belinda R. Avalos, MD, Edward A. Copelan, MD FACP, Saad Z Usmani, MD FACP, Manisha Bhutani, MD

Blood (2016) 128 (22): 378.

https://doi.org/10.1182/blood.V128.22.378.378

Published: 2016

Journal Articles

CYP2C19 Genotype-Guided Dosing and Voriconazole Concentrations in Hematopoietic Stem Cell Transplant Patients (HSCT) Receiving Antifungal Prophylaxis

Jai N Patel, PharmD, Myra M Robinson, Issam Hamadeh, PharmD, Zainab Shahid, MD, James T Symanowski, PhD, Dragos Plesca, PharmD, PhD, Margaret Croom, PharmD, Jigar Trivedi, MSc, PharmD, Nury M. Steuerwald, PhD, Belinda R. Avalos, MD, Edward A. Copelan, MD FACP

Blood (2016) 128 (22): 3416.

https://doi.org/10.1182/blood.V128.22.3416.3416

Published: 2016

Journal Articles

Fluorescence in Situ Hybridization (FISH) abnormalities and Baseline Clinical Features at Diagnosis in African American Multiple Myeloma Patients

Megan H Jagosky, MD, Kyle L Madden, BS, Blake B Goodbar, MD, Virginia Thurston, PhD, Manisha Bhutani, MD, Preeya Patel, BS, Myra M Robinson, Rupali Bose, Jill Eddy, Candice G Roth, RN, MSN, Lynn S Sanders, MSN, RN, OCN, James T Symanowski, PhD, Tammy D Cogdill, NP, Belinda R. Avalos, MD, Edward A. Copelan, MD FACP, Saad Z Usmani, MD FACP

Blood (2016) 128 (22): 2351.

https://doi.org/10.1182/blood.V128.22.2351.2351

Published: 2016

Journal Articles

Outcomes in Transplant Eligible Multiple Myeloma African American Patients Appear Similar to Caucasian Patients

Megan H Jagosky, MD, Kyle L Madden, BS, Myra M Robinson, Blake B Goodbar, MD, Manisha Bhutani, MD, Preeya Patel, BS, Rupali Bose, Jill Eddy, Sarah LeStrange, Candice G Roth, RN, MSN, Lynn S Sanders, MSN, RN, OCN, James T Symanowski, PhD, Tammy D Cogdill, NP, Dragos Plesca, PharmD, PhD, Belinda R. Avalos, MD, Edward A. Copelan, MD FACP, Saad Z Usmani, MD FACP

Blood (2016) 128 (22): 2352.

https://doi.org/10.1182/blood.V128.22.2352.2352

Published: 2016

Journal Articles

Establishment of Subspecialized Care in Hematologic Malignancies and a Hematopoietic Cell Transplantation Program

Edward A. Copelan, MD FACP, Jonathan M. Gerber, MD, Saad Z Usmani, MD FACP, Michael R. Grunwald, MD, Nilanjan Ghosh, MD PhD, Omotayo O. Fasan, MBBS, MRCP, Manisha Bhutani, MD, James T Symanowski, PhD, Derek Raghavan, MD PhD FACP, FRACP, FASCO, Belinda R. Avalos, MD

Blood (2016) 128 (22): 3580.

https://doi.org/10.1182/blood.V128.22.3580.3580

Published: 2016

NARROW

Factors Predicting Efficacy and Toxicity of Post Transplantation Cyclophosphamide for Graft Versus Host Disease Prevention in Hematopoietic Cell Transplantation Recipients: Interim Data of an Ongoing Study

Clonal Hematopoiesis Prevalence and Mutational Spectrum in Patients with Plasma Cell Disorders at the Time of Diagnosis and Its Impact on Clinical Features, Cardiovascular Complications, and Survival

Impact of Race, Ethnicity, and Social Determinants of Heath on Outcomes for Acute Myeloid Leukemia Patients in a System with Specialized Nurse Navigation

Heterodimerization of CSF3R Splice Variants and Mutants Alter Receptor Function

Clinical Characteristics and Outcomes of AML Patients Treated with Frontline CPX 351 or HMA/Venetoclax: A Single Institution's Experience

Platform Incorporating Patient Navigation, Preparative Guidelines, and Hospital at Home May Improve COVID-19 Outcomes for Patients with Myeloid Malignancies

CSF3R Splicing Regulates Granulopoiesis Via Splice Variant Specific Responses to G-CSF

Characteristics Affecting Durability and Tolerability of Imatinib in Patients Switched from Brand to Generic and Newly Diagnosed Patients Initially Prescribed Generic Imatinib for Chronic Myeloid Leukemia

Impact of Letermovir Prophylaxis on Voriconazole Exposure in Allogeneic Hematopoietic Cell Transplant Recipients

Complex CSF3R Protein Isoform Interactions Dictate Cytokine Responsiveness

Specialty Pharmacy and Physician Partnership Optimizes Clinical Pathway Adherence in Myelofibrosis (MF): Initial Analysis of a Quality Improvement Initiative

Minorities Do Not Have Worse Outcomes for Diffuse Large B Cell Lymphoma (DLBCL) If Optimally Managed

Patient Reported Financial Toxicity in Myeloproliferative Neoplasms

Alternative Splicing and Intronic Polyadenylation Post-Transcriptionally Regulate CSF3R Via a Cryptic Exon

New Germline Syndrome Discovery: Heterozygous CSF3R Mutations May Predispose to Myeloid and Lymphoid Malignancies

Peripheral Immune Profile and Minimal Residual Disease (MRD) Burden Following Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM)

CYP2C19 Genotype-Guided Dosing and Voriconazole Concentrations in Hematopoietic Stem Cell Transplant Patients (HSCT) Receiving Antifungal Prophylaxis

Fluorescence in Situ Hybridization (FISH) abnormalities and Baseline Clinical Features at Diagnosis in African American Multiple Myeloma Patients

Outcomes in Transplant Eligible Multiple Myeloma African American Patients Appear Similar to Caucasian Patients

Establishment of Subspecialized Care in Hematologic Malignancies and a Hematopoietic Cell Transplantation Program

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only